PTPN22 and type 1 diabetes mellitus: In 2018, the first results of a genome-wide association study of LADA were published; they detected the risk polymorphic variants inherent to T1DM (HLA, PTPN22, INS, etc.)and T2DM (THADA) and coupled with the disease.